Literature DB >> 7307346

Multiple serum inhibitors of lectin-induced lymphocyte proliferation in nephrotic syndrome.

A Martini, M A Vitiello, S Siena, V Capelli, A G Ugazio.   

Abstract

Inhibitory activity on PHA- and Con A-induced lymphocyte proliferation was observed in the serum of 29 patients with nephrotic syndrome (NS); this inhibitory activity was present both in steroid-sensitive nephrotic syndrome (SSNS; 18 patients) and in NS due to other glomerulopathies (11 patients). In order to characterize the inhibitory activity, peripheral blood lymphocytes from normal donors were stimulated with various concentrations of Con A in culture medium supplemented with: (1) 20% SSNS serum, (2) various concentrations (1, 5 and 20%) of either SSNS serum or normal human serum (NHS) and (3) 20% of a serum prepared by mixing different proportions of SSNS and NHS. The results suggest that the inhibitory activity is due to at least two different factors: (a) inhibitor(s) acting competitively with the lectin Con A, and (b) inhibitor(s) neutralized by factor(s) present in NHS. A disturbance in the normal equilibrium between inhibiting and enhancing factors which results in overall inhibition might well be a consequence of the marked alteration in serum proteins characteristic of NS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7307346      PMCID: PMC1537250     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Isolation of an immunosuppressive peptide fraction from human plasma.

Authors:  J C Occhino; A H Glasgow; S R Cooperband; J A Mannick; K Schmid
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

2.  Zinc transferrin. Enhancement of nucleic acid synthesis in phytohemagglutinin-stimulated human lymphocytes.

Authors:  J L Phillips; P Azari
Journal:  Cell Immunol       Date:  1974-01       Impact factor: 4.868

3.  Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.

Authors:  T M Barratt; J F Soothill
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

4.  Purification and properties of a lymphocyte inhibition factor from human serum.

Authors:  W H Ford; E A Caspary; B Shenton
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

5.  Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature.

Authors:  J Plager; L Stutzman
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

6.  Lymphocyte suppression associated with alpha globulin. Changes in cellular immunity.

Authors:  D R Burger; D P Lilley; R M Vetto
Journal:  Cell Immunol       Date:  1974-03-15       Impact factor: 4.868

7.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

8.  Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.

Authors:  G R Burgio; A G Ugazio; L Nespoli; A F Marcioni; A M Bottelli; F Pasquali
Journal:  Eur J Immunol       Date:  1975-09       Impact factor: 5.532

9.  Lipoprotein profiles in adult nephrotics.

Authors:  S R Newmark; C F Anderson; J V Donadio; R D Ellefson
Journal:  Mayo Clin Proc       Date:  1975-07       Impact factor: 7.616

10.  Inhibitory factors of lymphocyte transformation in sera from patients with minimal change nephrotic syndrome.

Authors:  M G Beale; P E Hoffsten; A M Robson; R P MacDermott
Journal:  Clin Nephrol       Date:  1980-06       Impact factor: 0.975

View more
  4 in total

Review 1.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

Review 2.  Cellular immunity in glomerulonephritis.

Authors:  H M Fillit; J B Zabriskie
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

3.  Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children.

Authors:  H W Schnaper; T M Aune
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

4.  T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Authors:  Diego H Aviles; Matti V Vehaskari; Kirk S Culotta; Jennifer Manning; Augusto C Ochoa; Arnold H Zea
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.